These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 17084559
1. p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment. Chen MF, Chen WC, Wu CT, Lin PY, Shau H, Liao SK, Yang CT, Lee KD. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1461-72. PubMed ID: 17084559 [Abstract] [Full Text] [Related]
2. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Chen MF, Keng PC, Shau H, Wu CT, Hu YC, Liao SK, Chen WC. Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):581-91. PubMed ID: 16414373 [Abstract] [Full Text] [Related]
3. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. Mol Carcinog; 2009 Jan 01; 48(1):24-37. PubMed ID: 18459128 [Abstract] [Full Text] [Related]
4. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW, Lin MC, Fung PC, Kung H, Jin DY. Biochem Biophys Res Commun; 2000 Feb 24; 268(3):921-7. PubMed ID: 10679306 [Abstract] [Full Text] [Related]
5. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH. Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094 [Abstract] [Full Text] [Related]
6. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells. Sung HY, Wu HG, Ahn JH, Park WY. Int J Radiat Biol; 2010 Sep 05; 86(9):780-90. PubMed ID: 20597837 [Abstract] [Full Text] [Related]
7. Role of peroxiredoxin I in rectal cancer and related to p53 status. Chen MF, Lee KD, Yeh CH, Chen WC, Huang WS, Chin CC, Lin PY, Wang JY. Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):868-78. PubMed ID: 20732753 [Abstract] [Full Text] [Related]
8. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function. Liu XF, Xia YF, Li MZ, Wang HM, He YX, Zheng ML, Yang HL, Huang WL. Cell Biol Int; 2006 Mar 01; 30(3):283-7. PubMed ID: 16448826 [Abstract] [Full Text] [Related]
9. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo]. Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS, Yang ZY, Liu JD, Rao GW. Yao Xue Xue Bao; 2007 Jan 01; 42(1):26-34. PubMed ID: 17520803 [Abstract] [Full Text] [Related]
10. Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. Han YH, Kim HS, Kim JM, Kim SK, Yu DY, Moon EY. FEBS Lett; 2005 Aug 29; 579(21):4897-902. PubMed ID: 16109412 [Abstract] [Full Text] [Related]
11. Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer. Zhang B, Wang Y, Liu K, Yang X, Song M, Wang Y, Bai Y. Biochem Pharmacol; 2008 Feb 01; 75(3):660-7. PubMed ID: 17976536 [Abstract] [Full Text] [Related]
12. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Park SH, Chung YM, Lee YS, Kim HJ, Kim JS, Chae HZ, Yoo YD. Clin Cancer Res; 2000 Dec 01; 6(12):4915-20. PubMed ID: 11156252 [Abstract] [Full Text] [Related]
13. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. Sun Y, Sun D, Li F, Tian L, Li C, Li L, Lin R, Wang S. Lung Cancer; 2007 Oct 01; 58(1):21-9. PubMed ID: 17624472 [Abstract] [Full Text] [Related]
14. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma. Park JJ, Chang HW, Jeong EJ, Roh JL, Choi SH, Jeon SY, Ko GH, Kim SY. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1196-202. PubMed ID: 19251091 [Abstract] [Full Text] [Related]
15. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Park JH, Kim YS, Lee HL, Shim JY, Lee KS, Oh YJ, Shin SS, Choi YH, Park KJ, Park RW, Hwang SC. Respirology; 2006 May 15; 11(3):269-75. PubMed ID: 16635084 [Abstract] [Full Text] [Related]
16. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models. Lee CH, Yao CF, Huang SM, Ko S, Tan YH, Lee-Chen GJ, Wang YC. Cancer; 2008 Aug 15; 113(4):815-25. PubMed ID: 18618576 [Abstract] [Full Text] [Related]
17. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Zhang AL, Russell PJ, Knittel T, Milross C. Prostate; 2007 Nov 01; 67(15):1630-40. PubMed ID: 17823933 [Abstract] [Full Text] [Related]
18. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed. Hara T, Omura-Minamisawa M, Kang Y, Cheng C, Inoue T. Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1485-95. PubMed ID: 18640498 [Abstract] [Full Text] [Related]
19. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. Zhang X, Zhang J, Wang L, Wei H, Tian Z. BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579 [Abstract] [Full Text] [Related]
20. Enhanced radiosensitization of p53 mutant cells by oleamide. Lee YJ, Chung DY, Lee SJ, Ja Jhon G, Lee YS. Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1466-74. PubMed ID: 16580498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]